Harnessing the Gut Microbiota to Potentiate the Efficacy of CAR T Cell Therapy Gabrielli, Giulia; Shouval, Roni; Ghilardi, Guido; More Gabrielli, Giulia; Shouval, Roni; Ghilardi, Guido; van den Brink, Marcel; Ruella, Marco Less HemaSphere. 7(9):e950, September 2023. Favorite PDF Permissions Open
CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them Vanhooren, Jolien; Dobbelaere, Rani; Derpoorter, Charlotte; More Vanhooren, Jolien; Dobbelaere, Rani; Derpoorter, Charlotte; Deneweth, Larissa; Van Camp, Laurens; Uyttebroeck, Anne; De Moerloose, Barbara; Lammens, Tim Less HemaSphere. 7(9):e937, September 2023. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use Bücklein, Veit; Perez, Ariel; Rejeski, Kai; More Bücklein, Veit; Perez, Ariel; Rejeski, Kai; Iacoboni, Gloria; Jurinovic, Vindi; Holtick, Udo; Penack, Olaf; Kharboutli, Soraya; Blumenberg, Viktoria; Ackermann, Josephine; Frölich, Lisa; Johnson, Grace; Patel, Kedar; Arciola, Brian; Mhaskar, Rahul; Wood, Anthony; Schmidt, Christian; Albanyan, Omar; Gödel, Philipp; Hoster, Eva; Bullinger, Lars; Mackensen, Andreas; Locke, Frederick; von Bergwelt, Michael; Barba, Pere; Subklewe, Marion; Jain, Michael D. Less HemaSphere. 7(8):e907, August 2023. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open SDC Infographic
Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data Lambert, Jérôme; Di Blasi, Roberta; Rabian, Florence; More Lambert, Jérôme; Di Blasi, Roberta; Rabian, Florence; Dourthe, Marie-Emilie; Baruchel, André; Thiéblemont, Catherine; Boissel, Nicolas; Levy, Vincent; Picat, Marie-Quitterie; Chevret, Sylvie Less HemaSphere. 7(6):e873, June 2023. Favorite PDF Permissions Open
Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data Lambert, Jérôme; Di Blasi, Roberta; Rabian, Florence; More Lambert, Jérôme; Di Blasi, Roberta; Rabian, Florence; Dourthe, Marie-Emilie; Baruchel, André; Thiéblemont, Catherine; Boissel, Nicolas; Levy, Vincent; Picat, Marie-Quitterie; Chevret, Sylvie Less HemaSphere. 7(6):e873, June 2023. Favorite PDF Permissions Open
An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHA Rejeski, Kai; Greco, Raffaella; Onida, Francesco; More Rejeski, Kai; Greco, Raffaella; Onida, Francesco; Sánchez-Ortega, Isabel; Bonini, Chiara; Sureda, Anna; Gribben, John G.; Yakoub-Agha, Ibrahim; Subklewe, Marion Less HemaSphere. 7(5):e889, May 2023. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open SDC Infographic
Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy Voltin, Conrad-Amadeus; Gödel, Philipp; Beckmann, Laura; More Voltin, Conrad-Amadeus; Gödel, Philipp; Beckmann, Laura; Heger, Jan-Michel; Kobe, Carsten; Kutsch, Nadine; Borchmann, Peter; Dietlein, Markus; Herrmann, Ken; Stelljes, Matthias; Rahbar, Kambiz; Lenz, Georg; Reinhardt, H. Christian; Teichert, Marcel; Noppeney, Richard; Albring, Jörn C.; Seifert, Robert; von Tresckow, Bastian; Flossdorf, Sarah; Hanoun, Christine Less HemaSphere. 7(1):e817, January 2023. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review Efficace, Fabio; Cannella, Laura; Sparano, Francesco; More Efficace, Fabio; Cannella, Laura; Sparano, Francesco; Giesinger, Johannes M.; Vignetti, Marco; Baron, Frédéric; Bruera, Eduardo; Luppi, Mario; Platzbecker, Uwe Less HemaSphere. 6(12):e802, December 2022. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open SDC
Chimeric Antigen Receptor T-cell Therapy: Imaging Response Criteria and Relation to Progression-free and Overall Survival Winkelmann, Michael; Rejeski, Kai; Blumenberg, Viktoria; More Winkelmann, Michael; Rejeski, Kai; Blumenberg, Viktoria; Bücklein, Veit L.; Ruzicka, Michael; Unterrainer, Marcus; Schmidt, Christian; Dekorsy, Franziska J.; Bartenstein, Peter; Ricke, Jens; von Bergwelt-Baildon, Michael; Subklewe, Marion; Kunz, Wolfgang G. Less HemaSphere. 6(10):e781, October 2022. Favorite PDF Permissions Open
Budget Impact Analysis of CAR T-cell Therapy for Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in Germany Skalt, Daniela; Moertl, Bernhard; von Bergwelt-Baildon, Michael; More Skalt, Daniela; Moertl, Bernhard; von Bergwelt-Baildon, Michael; Schmidt, Christian; Schoel, Wolfgang; Bücklein, Veit; Weiglein, Tobias; Dreyling, Martin; Berger, Karin Less HemaSphere. 6(7):e736, July 2022. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open SDC
CAR T-cell Infusion Following Checkpoint Inhibition Can Induce Remission in Chemorefractory Post-transplant Lymphoproliferative Disorder of the CNS Rösler, Wiebke; Bink, Andrea; Bissig, Marina; More Rösler, Wiebke; Bink, Andrea; Bissig, Marina; Imbach, Lukas; Marques Maggio, Ewerton; Manz, Markus G.; Müller, Thomas; Roth, Patrick; Rushing, Elisabeth; Widmer, Corinne; Zenz, Thorsten; von Moos, Seraina; Müller, Antonia M. S. Less HemaSphere. 6(7):e733, July 2022. Favorite PDF Permissions Open SDC
Anti-BCMA CAR T-cell Therapy: Changing the Natural History of Multiple Myeloma Puertas, Borja; Mateos, María-Victoria; González-Calle, Verónica Puertas, Borja; Mateos, María-Victoria; González-Calle, Verónica Less HemaSphere. 6(3):e691, March 2022. Favorite PDF Permissions Open
The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies Einsele, Hermann; Briones, Javier; Ciceri, Fabio; More Einsele, Hermann; Briones, Javier; Ciceri, Fabio; García Cadenas, Irene; Falkenburg, Fred; Bolaños, Natacha; Heemskerk, H.M. Mirjam; Houot, Roch; Hudecek, Michael; Locatelli, Franco; Morgan, Kate; Morris, Emma C.; O’Dwyer, Michael; Sierra, Jordi Gil; van den Brink, Marcel; van de Loosdrecht, Arjan A. Less HemaSphere. 5(10):e642, October 2021. Favorite PDF Permissions Open
High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell Therapy Yoshihara, Kyoko; Matsuda, Ikuo; Utsunomiya, Nobuto; More Yoshihara, Kyoko; Matsuda, Ikuo; Utsunomiya, Nobuto; Samori, Mami; Hirata, Saki; Okada, Masaya; Hirota, Seiichi; Higasa, Satoshi; Yoshihara, Satoshi Less HemaSphere. 5(9):e628, September 2021. Favorite PDF Permissions Open
CD38-specific Chimeric Antigen Receptor Expressing Natural Killer KHYG-1 Cells: A Proof of Concept for an “Off the Shelf” Therapy for Multiple Myeloma Stikvoort, Arwen; van der Schans, Jort; Sarkar, Subhashis; More Stikvoort, Arwen; van der Schans, Jort; Sarkar, Subhashis; Poels, Renée; Ruiter, Ruud; Naik, Jyoti; Yuan, Huipin; de Bruijn, Joost D.; van de Donk, Niels W. C. J.; Zweegman, Sonja; Themeli, Maria; Groen, Richard; O’Dwyer, Michael; Mutis, Tuna Less HemaSphere. 5(7):e596, July 2021. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open SDC
Understanding the Mechanisms of Resistance to T Cell-based Immunotherapies to Develop More Favorable Strategies in Multiple Myeloma Ahn, Sungwoo; Leblay, Noémie; Neri, Paola Ahn, Sungwoo; Leblay, Noémie; Neri, Paola Less HemaSphere. 5(6):e575, June 2021. Favorite PDF Permissions Open
Bone Marrow Mesenchymal Stromal Cell-mediated Resistance in Multiple Myeloma Against NK Cells can be Overcome by Introduction of CD38-CAR or TRAIL-variant Holthof, Lisa C.; Stikvoort, Arwen; van der Horst, Hilma J.; More Holthof, Lisa C.; Stikvoort, Arwen; van der Horst, Hilma J.; Gelderloos, Anne T.; Poels, Renée; Li, Fengzhi; Groen, Richard W. J.; Zweegman, Sonja; van de Donk, Niels W. C. J.; O’Dwyer, Michael; Mutis, Tuna Less HemaSphere. 5(5):e561, May 2021. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Hematologic Rescue of CAR T-cell–mediated Prolonged Pancytopenia Using Autologous Peripheral Blood Hematopoietic Stem Cells in a Lymphoma Patient Gödel, Philipp; Sieg, Noëlle; Heger, Jan-Michel; More Gödel, Philipp; Sieg, Noëlle; Heger, Jan-Michel; Kutsch, Nadine; Herling, Carmen; Bärmann, Ben-Niklas; Scheid, Christof; Borchmann, Peter; Holtick, Udo Less HemaSphere. 5(3):e545, March 2021. Favorite PDF Permissions Open
Clinicopathologic Findings in Fatal Neurotoxicity After Adoptive Immunotherapy With CD19-Directed CAR T-Cells Karschnia, Philipp; Strübing, Felix; Teske, Nico; More Karschnia, Philipp; Strübing, Felix; Teske, Nico; Blumenberg, Viktoria; Bücklein, Veit L.; Schmidt, Christian; Schöberl, Florian; Dimitriadis, Konstantinos; Forbrig, Robert; Stemmler, Hans-Joachim; Tonn, Joerg-Christian; von Bergwelt-Baildon, Michael; Subklewe, Marion; von Baumgarten, Louisa Less HemaSphere. 5(3):e533, March 2021. Favorite PDF Permissions Open
Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future Heine, Renaud; Thielen, Frederick W.; Koopmanschap, Marc; More Heine, Renaud; Thielen, Frederick W.; Koopmanschap, Marc; Kersten, Marie José; Einsele, Hermann; Jaeger, Ulrich; Sonneveld, Pieter; Sierra, Jorge; Smand, Carin; Uyl-de Groot, Carin A. Less HemaSphere. 5(2):e524, February 2021. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-cell Lymphoma in the Era of CAR-T Cell Therapy Lekakis, Lazaros J.; Moskowitz, Craig H. Lekakis, Lazaros J.; Moskowitz, Craig H. Less HemaSphere. 3(6):e295, December 2019. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Chimeric Antigen Receptor T-Cell Therapy Clinical Results in Pediatric and Young Adult B-ALL DiNofia, Amanda M.; Maude, Shannon L. DiNofia, Amanda M.; Maude, Shannon L. Less HemaSphere. 3(4):e279, August 2019. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
EHA Guidance Document The process of CAR-T cell therapy in Europe Less HemaSphere. 3(4):e280, August 2019. Favorite PDF Permissions Open
CAR T-cells: Driving in the Fast Lane Ansell, Stephen M.; Corradini, Paolo Ansell, Stephen M.; Corradini, Paolo Less HemaSphere. 3(3):e209, June 2019. Show More Show Less CAR T-cells: Driving in the Fast Lane Favorite PDF Permissions Open
Chimeric Antigen Receptor T Cells Targeting CD19 and Ibrutinib for Chronic Lymphocytic Leukemia Delgado, Julio; Caballero-Baños, Miguel; Ortiz-Maldonado, Valentín; More Delgado, Julio; Caballero-Baños, Miguel; Ortiz-Maldonado, Valentín; Castellà, Maria; Magnano, Laura; Juan, Manel; Urbano-Ispizua, Álvaro Less HemaSphere. 3(2):e174, April 2019. Favorite PDF Permissions Open
In the Eye of the Storm: Immune-mediated Toxicities Associated With CAR-T Cell Therapy Garcia Borrega, Jorge; Gödel, Philipp; Rüger, Maria Adele; More Garcia Borrega, Jorge; Gödel, Philipp; Rüger, Maria Adele; Onur, Özgür A.; Shimabukuro-Vornhagen, Alexander; Kochanek, Matthias; Böll, Boris Less HemaSphere. 3(2):e191, April 2019. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
CAR T Cell Toxicity: Current Management and Future Directions Yáñez, Lucrecia; Sánchez-Escamilla, Miriam; Perales, Miguel-Angel Yáñez, Lucrecia; Sánchez-Escamilla, Miriam; Perales, Miguel-Angel Less HemaSphere. 3(2):e186, April 2019. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
CAR-T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and Hope Hopfinger, Georg; Jäger, Ulrich; Worel, Nina Hopfinger, Georg; Jäger, Ulrich; Worel, Nina Less HemaSphere. 3(2):e185, April 2019. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
CAR-T Cells: Future Perspectives Charrot, Sarah; Hallam, Simon Charrot, Sarah; Hallam, Simon Less HemaSphere. 3(2):e188, April 2019. Favorite PDF Permissions Open
CAR T Cells: A Snapshot on the Growing Options to Design a CAR Holzinger, Astrid; Abken, Hinrich Holzinger, Astrid; Abken, Hinrich Less HemaSphere. 3(1):e172, February 2019. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
Chimeric Antigen Receptor-T Cell Therapy: Practical Considerations for Implementation in Europe Buechner, Jochen; Kersten, Marie José; Fuchs, Miriam; More Buechner, Jochen; Kersten, Marie José; Fuchs, Miriam; Salmon, Florence; Jäger, Ulrich Less HemaSphere. 2(1):e18, January-February 2018. Abstract Abstract Favorite PDF Permissions Go to Full Text of this Article Open
